首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Synergistic Antioxidant Effects of Araloside A and L-Ascorbic Acid on H 2 O 2 -Induced HEK293 Cells: Regulation of Cellular Antioxidant Status
【24h】

Synergistic Antioxidant Effects of Araloside A and L-Ascorbic Acid on H 2 O 2 -Induced HEK293 Cells: Regulation of Cellular Antioxidant Status

机译:芳钠A和L-抗坏血酸对H 2 O 2-诱导的HEK293细胞的协同抗氧化作用:细胞抗氧化状态的调节

获取原文
           

摘要

Araloside A is a pentacyclic triterpenoid saponin, and L-ascorbic acid is a globally recognized antioxidant. In this study, coadministered araloside A and L-ascorbic acid were found to have a strong synergistic antioxidant effect, and correlations between cellular antioxidant indexes and free radical scavenging ability were found. Individual and combined pretreatment with araloside A and L-ascorbic acid increased both cell viability and antioxidant enzyme activity and inhibited the release of lactate dehydrogenase (LDH); the accumulation of malondialdehyde (MDA), lipid peroxidation (LPO) products, and H 2 O 2 ; and the production of intracellular reactive oxygen species (ROS), protein carbonyls, and 8-hydroxy-2-deoxy guanosine (8-OHdG). Free radical scavenging ability was positively correlated with superoxide dismutase (SOD) and catalase (CAT) activity, the glutathione (GSH)/oxidized glutathione (GSSG) ratio, and total antioxidant capacity (T-AOC). Our study is the first investigation of araloside A and L-ascorbic acid coadministration for the treatment of diseases caused by oxidative stress. The synergistic antioxidant effects of araloside A and L-ascorbic acid support their potential as functional food ingredients for the elimination of oxidative stress-induced adverse reactions.
机译:araloIde A是五胞苷三萜类皂苷,L-抗坏血酸是全球公认的抗氧化剂。在该研究中,发现共析氧化物A和L-抗坏血酸具有强烈的协同抗氧化效果,并且发现了细胞抗氧化指标与自由基清除能力之间的相关性。用氮硼化物A和L-抗坏血酸的个体和组合预处理增加了细胞活力和抗氧化酶活性,并抑制乳酸脱氢酶(LDH)的释放;丙二醛(MDA),脂质过氧化(LPO)产品和H 2 O 2的积累;并生产细胞内反应性氧(ROS),蛋白质羰基和8-羟基-2-脱氧鸟苷(8-OHDG)。自由基清除能力与超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性呈正相关,谷胱甘肽(GSH)/氧化谷胱甘肽(GSSG)比和总抗氧化能力(T-AOC)。我们的研究是第一次调查氨罗硼胺A和L-抗坏血酸共同分子用于治疗氧化应激引起的疾病。 Aralodide A和L-抗坏血酸的协同抗氧化作用支持它们作为功能性食品成分的潜力,以消除氧化应激诱导的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号